-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
29 Oct 2025
-
Net transactions value
-
-$2,576,869
-
Form type
-
4
-
Filing time
-
31 Oct 2025, 17:12:46 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| ROTHBLATT MARTINE A |
Chairperson & CEO, Director |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
30 Oct 2025 |
0001106578 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$481,040 |
+4,000 |
+3077% |
$120.26 |
4,130 |
29 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$476,641 |
-1,100 |
-27% |
$433.31 |
3,030 |
29 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$870,480 |
-2,000 |
-66% |
$435.24 |
1,030 |
29 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$395,991 |
-900 |
-87% |
$439.99 |
130 |
29 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$481,040 |
+4,000 |
+3077% |
$120.26 |
4,130 |
30 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$670,702 |
-1,500 |
-36% |
$447.14 |
2,630 |
30 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$242,598 |
-541 |
-21% |
$448.42 |
2,089 |
30 Oct 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
$656,891 |
-1,459 |
-70% |
$450.23 |
630 |
30 Oct 2025 |
Direct |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
$225,645 |
-500 |
-79% |
$451.29 |
130 |
30 Oct 2025 |
Direct |
F1 |
| holding |
UTHR |
Common Stock |
|
|
|
|
|
166 |
29 Oct 2025 |
by Spouse |
|
| holding |
UTHR |
Common Stock |
|
|
|
|
|
324,518 |
29 Oct 2025 |
by Trust |
F3 |
| holding |
UTHR |
Common Stock |
|
|
|
|
|
258,117 |
29 Oct 2025 |
by Trust |
F4 |
| holding |
UTHR |
Common Stock |
|
|
|
|
|
45,596 |
29 Oct 2025 |
by Trust |
F5 |
| holding |
UTHR |
Common Stock |
|
|
|
|
|
15,962 |
29 Oct 2025 |
by Trust |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-4,000 |
-2.7% |
$0.000000 |
142,000 |
29 Oct 2025 |
Common Stock |
4,000 |
$120.26 |
Direct |
F1 |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-4,000 |
-2.8% |
$0.000000 |
138,000 |
30 Oct 2025 |
Common Stock |
4,000 |
$120.26 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: